Strong CAGR to Propel in the Heart Closure Devices Market and Beyond upto $4.87 Billion by 2029
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Has the Heart Closure Devices Market Growth Performance Trended Historically, And What Lies Ahead?
The market size of heart closure devices has witnessed an accelerated growth lately. It is set to expand from a value of $2.77 billion in 2024 to about $3.10 billion in 2025, attaining a compound annual growth rate (CAGR) of 12.2%. The previously recorded growth can be credited to heightened awareness amongst healthcare professionals, a rise in device approvals by regulatory bodies, favorable reimbursement policies, escalating cases of cardiovascular diseases, and a rising elderly population.
In the forthcoming years, the market size of heart closure devices is slated to witness a swift expansion, growing to a remarkable $4.87 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 11.9%. This projected growth during the forecast period can be credited to several factors including an uptick in congenital heart defects, escalating use of MRI procedures, an increase in occurrences of heart strokes, a rise in atrial fibrillation incidents, and a growing inclination toward minimally invasive procedures. The forecast period will also see major trends such as the amalgamation of multi-functional devices, advancements in technology, innovation in materials and design, the incorporation of imaging technologies, and novel developments in bioresorbable materials.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20828&type=smp
Which Primay Drivers Are Accelerating Growth in the Heart Closure Devices Market?
The heart closure devices market growth is likely to be fueled by the escalating number of cardiovascular diseases (CVDs). Aging, unhealthy lifestyle choices, genetic predisposition, and a heightened prevalence of risk factors such as hypertension, diabetes, and obesity, are factors contributing to the rise in CVDs. Heart closure devices ameliorate congenital heart defect complications by minimally invasively closing unconventional heart openings, enhancing blood circulation, and preventing further health complications. For instance, the Singapore Heart Foundation (SHF) reported in May 2024 that the total deaths from cardiovascular disease stood at 26,885 in 2023. Also, deaths from ischemic heart disease increased to 5,302 from 5,290 deaths in 2022. Owing to this, the growing prevalence of cardiovascular diseases (CVDs) remains a significant driver of the heart closure devices market.
Which Primary Segments of the Heart Closure Devices Market Are Driving Growth and Industry Transformations?
The heart closure devices market covered in this report is segmented –
1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery
4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices
2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices
4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices
5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20828&type=smp
Which Regions Are Key Players in the Growth of the Heart Closure Devices Market?
North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Heart Closure Devices Market?
Leading firms in the heart closure devices market are concentrating on the creation of cutting-edge technologies like patent foramen ovale occlusion systems to enhance patient outcomes and minimize procedural complications. Patent foramen ovale (PFO) occlusion systems, a type of medical device for sealing a PFO—a persistent aperture in the heart between the right and left atria which should have naturally sealed post-birth but stays open—are being innovated. For instance, in September 2022, Abbott Laboratories, a medical devices company based in the US, introduced the Amplatzer Talisman PFO Occlusion System. This groundbreaking device aims to assist people with PFO, especially those who have suffered a stroke and face a high recurrence risk. The system comes with an already attached occluder to simplify procedures, a versatile 30mm size for increased adaptability, and a completely recapturable design, to ensure effective closure of PFO, thus reducing the possibilities of future strokes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report
What Parameters Are Used to Define the Heart Closure Devices Market?
Heart closure devices are advanced medical tools designed to seal holes or openings in the heart, commonly arising from congenital defects or surgical interventions. They are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart abnormalities. These minimally invasive devices are typically delivered through catheter-based procedures, offering a safer alternative to open-heart surgery.?
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20828
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model